Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Fuji
Mallinckrodt
Merck
UBS
Medtronic
Accenture
Baxter
QuintilesIMS
Express Scripts

Generated: January 18, 2018

DrugPatentWatch Database Preview

NOVOTHYROX Drug Profile

« Back to Dashboard

When do Novothyrox patents expire, and when can generic versions of Novothyrox launch?

Novothyrox is a drug marketed by Merck Kgaa and is included in one NDA.

The generic ingredient in NOVOTHYROX is levothyroxine sodium. There are ten drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.

US Patents and Regulatory Information for NOVOTHYROX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck Kgaa NOVOTHYROX levothyroxine sodium TABLET;ORAL 021292-001 May 31, 2002 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Merck Kgaa NOVOTHYROX levothyroxine sodium TABLET;ORAL 021292-007 May 31, 2002 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Merck Kgaa NOVOTHYROX levothyroxine sodium TABLET;ORAL 021292-004 May 31, 2002 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Merck Kgaa NOVOTHYROX levothyroxine sodium TABLET;ORAL 021292-012 May 31, 2002 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Merck Kgaa NOVOTHYROX levothyroxine sodium TABLET;ORAL 021292-008 May 31, 2002 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Merck Kgaa NOVOTHYROX levothyroxine sodium TABLET;ORAL 021292-002 May 31, 2002 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Merck Kgaa NOVOTHYROX levothyroxine sodium TABLET;ORAL 021292-003 May 31, 2002 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Merck Kgaa NOVOTHYROX levothyroxine sodium TABLET;ORAL 021292-006 May 31, 2002 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Merck Kgaa NOVOTHYROX levothyroxine sodium TABLET;ORAL 021292-005 May 31, 2002 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Merck Kgaa NOVOTHYROX levothyroxine sodium TABLET;ORAL 021292-010 May 31, 2002 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Cerilliant
Healthtrust
Covington
Chinese Patent Office
Colorcon
Novartis
Cipla
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot